Dr. Richard Frye Presents Understanding The Overlap of PANS and Autism –
An Overview of Research on Antineuronal Antibodies in Patients With Autism
Continuing Medical Education Credit (CME)
Join this CME webinar on March 12, 2019, by signing up at The Foundation for Children with Neuroimmune Disorders
(Continuing medical education (CME) refers to a specific form of continuing education (CE) that helps those in the medical field maintain competence and learn about new and developing areas of their field; however, parents are also invited to listen to this invaluable educational opportunity.)
Who is Dr. Richard Frye, MD, Ph.D.?
Dr. Richard Frye, MD, Ph.D. Chief of the Division of Neurodevelopment Disorders, Phoenix Children’s Hospital. Understanding The Overlap of PANS and Autism – An Overview of Research on Antineuronal Antibodies in Patients With Autism. March 12, 2019, 7:30-8:30 pm CST CME Credit opportunity
Dr. Richard Frye is a Child Neurologist with expertise in neurodevelopmental and neurometabolic disorders. He received an MD and Ph.D. in Physiology and Biophysics from Georgetown University. He completed a residency in Pediatrics at the University of Miami, Residency in Child Neurology and Fellowship in Behavioral Neurology and Learning Disabilities at Harvard University/Children’s Hospital Boston and Fellowship in Psychology at Boston University
He also received a Masters in Biomedical Science and Biostatistics from Drexel University as well as board certifications in General Pediatrics, and in Neurology with Special Competence in Child Neurology. Dr Frye has authored over 150 peer-reviewed publications and book chapters and serves on several editorial boards. Frye MD has conducted several clinical trials demonstrating the efficacy of safe and novel treatments that target underlying physiological abnormalities in children with neurodevelopmental disorders.
Description of Dr. Frye’s presentation:
Many autoantibodies have been reported in children with autism spectrum disorder (ASD). Many of these autoantibodies interfere with brain function, resulting in the diagnosis of autoimmune encephalopathy (AIE). Identifying the particularly autoantibodies that cause AIE in ASD and how to treat such abnormalities is an evolving area of medicine. This talk will discuss the autoantibodies associated with AIE in ASD and the latest research regarding potential treatments, including leucovorin calcium and intravenous immunoglobulin (IVIG). This talk will provide an overview of some of the immune mechanisms that may be causative of ASD symptoms and an evidence-based review of implications for their treatment. CME (continuing MedED) Join us during this continuing medical education CME opportunity for physicians
· Discuss the latest research regarding the role of the immune system in autism spectrum disorder (ASD)
· Review current evidence regarding which auto-antibodies may cause significant symptoms in children with ASD
· Discuss research regarding the improvement of symptoms caused by autoantibodies in children with ASD